Calidi Biotherapeutics Stock (AMEX: CLDI) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 19.000 / 1.036M |
Day Range | - - - |
52 Wk Range | 0.144 - 5.000 |
Market Cap | $11.099M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 39 |
Short Interest | 3.83% |
Days to Cover | 1.35 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Calidi Biotherapeutics (AMEX: CLDI) through any online brokerage.
Other companies in Calidi Biotherapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Dominari Holdings (NASDAQ:DOMH), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR) and Addex Therapeutics (NASDAQ:ADXN).
The latest price target for Calidi Biotherapeutics (AMEX: CLDI) was reported by Baird on Thursday, March 21, 2024. The analyst firm set a price target for 4.50 expecting CLDI to fall to within 12 months (a possible NaN% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Calidi Biotherapeutics (AMEX: CLDI) is $ last updated .
There are no upcoming dividends for Calidi Biotherapeutics.
Calidi Biotherapeutics’s Q1 earnings are confirmed for Wednesday, May 22, 2024.
There is no upcoming split for Calidi Biotherapeutics.
Calidi Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.